Company Directory - Research & Development
Peak Analysis & Automation (PAA) is a leading supplier of intelligent laboratory automation solutions, trusted by scientists across the globe within the pharmaceutical and biotechnology industries. The company designs and builds an extensive range of laboratory workcells and robots, storage products and automation accessories as well as providing its own unique software solutions.
The company is the brainchild of three very different individuals, who share a common belief: Phage-based drugs are humanities best bet for developing the next generation of anti-bacterials. After working with both engineered phages and synthetic lysins, the company focused on its synthetic lysin platform, the LysinBuilder in 2020.
Pionyr Immunotherapeutics is a clinical stage company developing cancer immunotherapies that target the tumor microenvironment to enhance the body’s antitumor immunity.
At Precision BioSciences, leaders in genome editing utilize the ARCUS® editing platform to eliminate cancers, cure genetic diseases, and create safer, more productive food sources.
Prokarium is a venture-backed biotechnology company developing microbial immunotherapies and vaccines.
We’re Prometheus Biosciences, an innovative biotechnology company performing groundbreaking science to discover and develop novel therapeutic and companion diagnostic product candidates for the treatment of immune-mediated diseases, starting first with inflammatory bowel disease (IBD).
Proregulations is an experienced regulatory consulting firm. We provide high-quality regulatory and scientific consulting services for companies in the industrial chemicals, food and food contact materials.
Proteomedix was founded in 2010 to bring together the exceptional and specific expertise of a multi-disciplinary group of the world’s leading scientists and clinicians. As a medical need-oriented organization with a strong focus on research and development, it relies on a powerful network of clinicians, IVD experts, pharmacists and marketers.
Protheragen-ING helps clients achieve cost-effective improvements in their R&D productivity. Our technical and scientific teams provide reliable products and solutions to the global chemical industry.
Provitro stands for more than ten years of experience in commercialisation of cell culture technologies and tissue microarrays backed up by scientific knowledge and resources of immunohistochemical analyses at the Pathological Institute of Charité Universitätsmedizin Berlin.
Q32 Bio is a clinical stage biotechnology company developing biologic therapeutics targeting powerful regulators of the innate and adaptive immune systems to re-balance immunity in severe autoimmune and inflammatory diseases.
Quotient Sciences is a drug development and manufacturing accelerator supporting customers across the entire development pathway from candidate selection to commercial launch.
Our mission is to develop and implement innovative precision medicine strategies for patients suffering from cancer. To make our vision a reality, our team is relentless, unshaken by obstacles, fiercely aware that someone needs us now and committed to harnessing tumor biology to develop vanguard therapies to treat patients. Live. Life. To the Fullest.
We are an integrated genetic medicines company developing targeted, disease-modifying medicines for patients with life-limiting respiratory diseases. Our treatments address the underlying genetic cause in underserved populations and have the potential to tremendously impact the quality and length of patients’ lives.
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development.
Established in 2003 by preeminent Japanese university researchers, REPROCELL quickly became the leading stem cell research company in Japan. Soon thereafter, REPROCELL products were employed by Professor Shinya Yamanaka (Nobel Laureate, 2012) during his pioneering research on induced pluripotent stem cell (iPSC) technologies at Kyoto University.
